$245.39
1.12% today
NYSE, Sep 19, 06:14 pm CET
ISIN
US46266C1053
Symbol
IQV

IQVIA Stock price

$242.67
-0.44 0.18% 1M
-11.20 4.41% 6M
+11.29 4.88% YTD
+33.32 15.92% 1Y
-10.50 4.15% 3Y
+89.23 58.15% 5Y
+185.67 325.74% 10Y
NYSE, Closing price Wed, Sep 18 2024
+2.69 1.12%
ISIN
US46266C1053
Symbol
IQV
Sector

Key metrics

Market capitalization $44.24b
Enterprise Value $56.01b
P/E (TTM) P/E ratio 31.47
EV/FCF (TTM) EV/FCF 30.66
EV/Sales (TTM) EV/Sales 3.69
P/S ratio (TTM) P/S ratio 2.92
P/B ratio (TTM) P/B ratio 6.59
Revenue growth (TTM) Revenue growth 3.45%
Revenue (TTM) Revenue $15.16b
EBIT (operating result TTM) EBIT $2.11b
Free Cash Flow (TTM) Free Cash Flow $1.83b
Cash position $1.68b
EPS (TTM) EPS $7.71
P/E forward 31.67
P/S forward 2.86
EV/Sales forward 3.62
Short interest 1.74%
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

20x Buy
74%
7x Hold
26%

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

Buy
74%
Hold
26%

Financial data from IQVIA

Assets
Jun '24
5,622 5,622
Cash 1,678 1,678
Claims 3,296 3,296
Inventories - -
Other current assets Other current assets Current assets 648 648
20,776 20,776
Property, plant and equipment 768 768
Financial assets 287 287
Intangible Assets 19,085 19,085
Other fixed assets Other assets Fixed assets 636 636
Total Assets 26,398 26,398
Liabilities
Jun '24
Equity 6,714 6,714
19,684 19,684
Current liabilities 6,620 6,620
Non-current liabilities 13,064 13,064
Total Capital 26,398 26,398

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Business Wire
about 4 hours ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Frost & Sullivan, a leading independent research and consulting firm, has awarded IQVIA with the 2024 Global Customer Value Leadership Award for excellence in the global artifici...
Neutral
PRNewsWire
15 days ago
PHILADELPHIA , Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
Neutral
Business Wire
29 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Healthcare Conference in New York on Wednesday, September 4, 2024 at 10:00 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations webs...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 87,000
Founded 1950
Website www.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today